Unlocking the Potential of Medical Imaging as Real-World Data

摘要

The FDA's definition of "real-world data" (RWD) includes "data derived from electronic health records, medical claims data, data from product or disease registries, and data gathered from other sources (such as digital health technologies) that can inform on health status." Under this definition, medical imaging can certainly be understood as a type of RWD. However, in the drug development process, where RWD is playing an increasingly important role, medical imaging is not often among the data that teams are actively leveraging.